Table 3.
Basal ganglia volumes | |||
---|---|---|---|
Above median | Below median | (t, r, p) | |
N | 42 | 42 | |
CD4 cell counts | |||
Current | 515.7 (278) | 566.3 (262) | −.82, .09, >.10 |
Nadira | 213.4 (138) | 238.5 (114) | −.80, .10, >.10 |
HIV viral load | |||
Current | 1.94 (.79) | 2.18 (1.06) | −1.17, .13, >.10 |
Peakb | 5.03 (.56) | 4.92 (.66) | .68, −.09, >.10 |
Years since first positive visitc | 13.1 (8.6) | 20.3 (5.6) | 4.53, .45, <.001 |
Years since seroconversion (n =19) | 12.0 (6.8) | 16.8 (4.8) | 1.74, .39, .10 |
Use of HAART (Percent (N)) | 83 (35) | 74 (31) | 1.20, −.12, .55d |
Rank of HAART CNS penetrance | 1.71 (.76) | 1.63 (.66) | 0.473, .003, .648 |
aLowest measured CD4+ cell count prior to HAART (n = 65)
bHighest HIV RNA prior to HAART (n = 65)
cVisit with first confirmed HIV seropositivity. Includes both prevalent and incident cases (n = 84)
dχ2, r, p